NEW YORK (GenomeWeb News) – South Korean firm Boram Pharm has filed a patent infringement suit in the US against Life Technologies alleging infringement of a patent covering technology for producing recombinant viruses.
The suit was filed last week in the US District Court for the District of Delaware. Boram claims that Life Technologies is infringing US Patent No. 7,319,001, titled "High throughput system for producing recombinant viruses using site-specific recombination." The patent was issued on Jan. 15, 2008 to Neurogenex, which is now owned by Boram.
In the suit, Boarm claims that Life Technologies' BaculoDirect Baculovirus Expression System infringes the patent.
It has asked the court to declare that Life Technologies has willfully infringed the patent, enjoin Life Tech from further alleged infringement, award compensatory damages, and treble the damages amount.